Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.8K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.8K
Inflammatory Response01:28

Inflammatory Response

16.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

2.9K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
2.9K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

14.8K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.8K
T Cell Types and Functions01:24

T Cell Types and Functions

2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment Options for Metallo-Beta-Lactamase-Producing <i>Enterobacterales</i> in the Era of Increasing Resistance.

International journal of molecular sciences·2026
Same author

A CXCL10-Expressing Influenza Vector Induces Robust Adaptive Immunity Despite Strong Attenuation.

Pharmaceutics·2026
Same author

Dual Ionizable Lipids (ALC0315 and SM102) in a Novel Lipid Nanoparticle Formulation Enhance In Vivo Delivery and Time-Dependent Expression of Messenger RNA and Self-Amplifying RNA.

ChemMedChem·2026
Same author

Neomycin Exhibits Immunomodulatory and Antiviral Activity Against Influenza B Virus.

Viruses·2026
Same author

Novel Small Molecule GLP-1R Agonists Based on 1<i>H</i>-Benzo[<i>d</i>]imidazole-5-Carboxylic Acid Scaffold.

Molecules (Basel, Switzerland)·2026
Same author

A comprehensive analysis of the use of nucleoside analogues in RNA therapeutics.

Journal of translational medicine·2026

Related Experiment Video

Updated: Jan 16, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.2K

The Interplay Between Therapeutic Self-Amplifying RNA and the Innate Immune System: Balancing Efficiency and

Dmitry Kunyk1, Marina Plotnikova2, Mikhail Bespalov1

  • 1Translational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.

International Journal of Molecular Sciences
|September 27, 2025
PubMed
Summary

Self-amplifying RNA (saRNA) offers potent therapeutic potential but requires safety assessments due to its interaction with the innate immune system. This review explores saRNA

Keywords:
RLRVEEVclinical developmentimmunityoptimizationreactogenicityrepliconsaRNAself-amplifying RNAtherapeuticsvaccine

More Related Videos

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.7K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

13.0K

Related Experiment Videos

Last Updated: Jan 16, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.2K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.7K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

13.0K

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Biology

Background:

  • Self-amplifying RNA (saRNA) is a novel platform for developing vaccines, anti-tumor agents, and gene therapies.
  • saRNA enables prolonged protein expression from small therapeutic doses.
  • Biosafety concerns arise from auxiliary sequences encoding alphavirus proteins essential for saRNA replication.

Purpose of the Study:

  • To review the interaction of saRNA with the innate immune system.
  • To analyze side effects of saRNA therapeutics from preclinical and clinical trials.
  • To discuss mechanisms of saRNA function, reactogenicity, and optimization strategies.

Main Methods:

  • Analysis of preclinical and clinical trial data for saRNA therapeutics.
  • Discussion of mechanisms underlying saRNA function and reactogenicity.
  • Review of optimization approaches to mitigate innate immune response and cytopathic effects.

Main Results:

  • Candidate saRNA therapeutics have shown specific side effects in trials.
  • Mechanisms of saRNA function are linked to alphavirus genomes and innate immune activation.
  • Optimization strategies aim to reduce immune activation and cytopathic effects.

Conclusions:

  • saRNA technology presents significant therapeutic advantages but necessitates careful biosafety evaluation.
  • Understanding saRNA's interaction with the innate immune system is crucial for safety.
  • Optimizing saRNA design can lead to safer and more effective therapeutic applications.